These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20184923)
1. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin. Sánchez-Margalet V; González-Yanes C; Najib S; Santos-Alvarez J Regul Pept; 2010 Apr; 161(1-3):8-14. PubMed ID: 20184923 [TBL] [Abstract][Full Text] [Related]
2. Reprint of: Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin. Sánchez-Margalet V; González-Yanes C; Najib S; Santos-Álvarez J Regul Pept; 2010 Nov; 165(1):71-7. PubMed ID: 20934461 [TBL] [Abstract][Full Text] [Related]
3. Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin. Zhang K; Rao F; Wen G; Salem RM; Vaingankar S; Mahata M; Mahapatra NR; Lillie EO; Cadman PE; Friese RS; Hamilton BA; Hook VY; Mahata SK; Taupenot L; O'Connor DT Diabetes Obes Metab; 2006 Nov; 8(6):621-33. PubMed ID: 17026486 [TBL] [Abstract][Full Text] [Related]
4. Pancreastatin is an endogenous peptide that regulates glucose homeostasis. Valicherla GR; Hossain Z; Mahata SK; Gayen JR Physiol Genomics; 2013 Nov; 45(22):1060-71. PubMed ID: 24064537 [TBL] [Abstract][Full Text] [Related]
5. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes. González-Yanes C; Sánchez-Margalet V Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813 [TBL] [Abstract][Full Text] [Related]
6. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells. Díaz-Troya S; Najib S; Sánchez-Margalet V Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712 [TBL] [Abstract][Full Text] [Related]
7. Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism. O'Connor DT; Cadman PE; Smiley C; Salem RM; Rao F; Smith J; Funk SD; Mahata SK; Mahata M; Wen G; Taupenot L; Gonzalez-Yanes C; Harper KL; Henry RR; Sanchez-Margalet V J Clin Endocrinol Metab; 2005 Sep; 90(9):5414-25. PubMed ID: 15956083 [TBL] [Abstract][Full Text] [Related]
8. Pancreastatin, a chromogranin A-derived peptide, activates Galpha(16) and phospholipase C-beta(2) by interacting with specific receptors in rat heart membranes. González-Yanes C; Santos-Alvarez J; Sánchez-Margalet V Cell Signal; 2001 Jan; 13(1):43-9. PubMed ID: 11257446 [TBL] [Abstract][Full Text] [Related]
9. Autocrine regulation of parathyroid secretion: inhibition of secretion by chromogranin-A (secretory protein-I) and potentiation of secretion by chromogranin-A and pancreastatin antibodies. Fasciotto BH; Gorr SU; Bourdeau AM; Cohn DV Endocrinology; 1990 Sep; 127(3):1329-35. PubMed ID: 2387256 [TBL] [Abstract][Full Text] [Related]
10. A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis. Gayen JR; Saberi M; Schenk S; Biswas N; Vaingankar SM; Cheung WW; Najjar SM; O'Connor DT; Bandyopadhyay G; Mahata SK J Biol Chem; 2009 Oct; 284(42):28498-509. PubMed ID: 19706599 [TBL] [Abstract][Full Text] [Related]
11. Pancreastatin inhibits insulin action in rat adipocytes. Sánchez-Margalet V; González-Yanes C Am J Physiol; 1998 Dec; 275(6):E1055-60. PubMed ID: 9843749 [TBL] [Abstract][Full Text] [Related]
12. Pancreastatin: further evidence for its consideration as a regulatory peptide. Sánchez-Margalet V; Lucas M; Goberna R J Mol Endocrinol; 1996 Feb; 16(1):1-8. PubMed ID: 8672228 [TBL] [Abstract][Full Text] [Related]
13. An adipocentric view of signaling and intracellular trafficking. Mora S; Pessin JE Diabetes Metab Res Rev; 2002; 18(5):345-56. PubMed ID: 12397577 [TBL] [Abstract][Full Text] [Related]
14. Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells. Sánchez-Margalet V Diabetologia; 1999 Mar; 42(3):317-25. PubMed ID: 10096784 [TBL] [Abstract][Full Text] [Related]
15. Current status on chromogranin A and pancreastatin. Robberecht P; Lingier P; Woussen-Colle MC Acta Gastroenterol Belg; 1993; 56(3-4):261-3. PubMed ID: 8266767 [TBL] [Abstract][Full Text] [Related]
16. The immunomodulatory functions of chromogranin A-derived peptide pancreastatin. Ioannidis M; Mahata SK; van den Bogaart G Peptides; 2022 Dec; 158():170893. PubMed ID: 36244579 [TBL] [Abstract][Full Text] [Related]
17. Pancreastatin and bovine parathyroid cell secretion. Drees BM; Hamilton JW Bone Miner; 1992 Jun; 17(3):335-46. PubMed ID: 1623328 [TBL] [Abstract][Full Text] [Related]
19. Novel peptide pancreastatin: its occurrence and codistribution with chromogranin A in the central nervous system of the pig. Kar S; Bretherton-Watt D; Gibson SJ; Steel JH; Gentleman SM; Roberts GW; Valentino K; Tatemoto K; Ghatei MA; Bloom SR J Comp Neurol; 1989 Oct; 288(4):627-39. PubMed ID: 2808753 [TBL] [Abstract][Full Text] [Related]
20. Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system. Helle KB Results Probl Cell Differ; 2010; 50():21-44. PubMed ID: 20217490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]